Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB

• Main Authors: Chang, Zi Wei, Goh, Yun Shan, Rouers, Angeline, Fong, Siew-Wai, Tay, Matthew Zirui, Chavatte, Jean-Marc, Hor, Pei Xiang, Loh, Chiew Yee, Huang, Yuling, Tan, Yong Jie, Neo, Vanessa, Kam, Isaac Kai Jie, Yeo, Nicholas Kim-Wah, Tan, Eunice X., Huang, Daniel, Wang, Bei, Siti Nazihah Mohd Salleh, Ngoh, Eve Zi Xian, Wang, Cheng-I, Leo, Yee-Sin, Lin, Raymond Tzer Pin, Lye, David C., Young, Barnaby Edward, Muthiah, Mark, Ng, Lisa F. P., Rénia, Laurent
• Other Authors: Lee Kong Chian School of Medicine (LKCMedicine)
• Format: Article
• Language: English
• Published: 2023
• Subjects: Science::Medicine; SARS-CoV-2; Spike Protein
• Online Access: https://hdl.handle.net/10356/171510
• Institution: Nanyang Technological University

Vaccine immunogenicity in transplant recipients can be impacted by the immunosuppressive (IS) regimens they receive. While BNT162b2 vaccination has been shown to induce an immune response in liver transplant recipients (LTRs), it remains unclear how different IS regimens may affect vaccine immunogen...